ARTW vs CVR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARTW exhibits weak financial health with a Piotroski F-Score of 2/9, indicating significant operational and financial distress. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given negative operating margins and declining revenue. While the stock trades below its Graham Number ($3.42) and has a low Price/Book ratio, these value indicators are undermined by deteriorating fundamentals, including a 17.9% YoY revenue decline and negative operating margin. The lack of analyst coverage and neutral insider activity further limit conviction. Overall, the company appears fundamentally challenged despite some apparent undervaluation.
CVR exhibits extreme financial distress, anchored by a Piotroski F-Score of 0/9 and an explicit 'going concern' warning in its latest 10-K filing. While the company maintains a low debt-to-equity ratio and high current ratio, these are overshadowed by recurring operating losses and negative cash flows. The discrepancy between reported revenue growth and the auditor's warning suggests a volatile operational environment with unsustainable costs. The current dividend is fundamentally unsupported by earnings, with a payout ratio exceeding 225%.
Compare Another Pair
Related Comparisons
ARTW vs CVR: Head-to-Head Comparison
This page compares Art's-Way Manufacturing Co., Inc. (ARTW) and Chicago Rivet & Machine Co. (CVR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.